Verbanck, S., C. Darquenne, G. K. Prisk, W. Vincken, and M. Paiva. A source of experimental underestimation of aerosol bolus deposition. J. Appl. Physiol. 86(3): 1067-1074, 1999.-We examined the measurement error in inhaled and exhaled aerosol concentration resulting from the bolus delivery system when small volumes of monodisperse aerosols are inspired to different lung depths. A laser photometer that illuminated ϳ75% of the breathing path cross section recorded low inhaled bolus half-widths (42 ml) and negative deposition values for shallow bolus inhalation when the inhalation path of a 60-ml aerosol was straight and unobstructed. We attributed these results to incomplete mixing of the inhaled aerosol bolus over the breathing path cross section, on the basis of simultaneous recordings of the photometer with a particle-counter sampling from either the center or the edge of the breathing path. Inserting a 90°bend into the inhaled bolus path increased the photometer measurement of inhaled bolus half-width to 57 ml and yielded positive deposition values. Dispersion, which is predominantly affected by exhaled bolus half-width, was not significantly altered by the 90°bend. We conclude that aerosol bolusdelivery systems should ensure adequate mixing of the inhaled bolus to avoid error in measurement of bolus deposition. inspired bolus characteristics; aerosol deposition; photometer; particle counter A NUMBER OF EXPERIMENTAL STUDIES on normal subjects (3, 5) and in various groups of patients (1, 2, 4) use the analysis of expired aerosol concentration which is recovered after inhalation of a predefined aerosol bolus. The inspired bolus is a small aerosol volume that ranges between 20 and 300 ml (3, 5). Lung behavior is then usually characterized in terms of aerosol bolus dispersion and/or deposition. Usually, deposition is determined for aerosol boluses delivered at various lung depths by varying the air volume after the aerosol bolus, while keeping preinspiratory lung volume and total inspired volume constant. Deposition is then plotted as a function of penetration volume (Vp), defined as the volumetric difference between the occurrence of inspired aerosol peak and the end of inspiration. For any inhaled bolus, some deposition is likely to occur; therefore, measured deposition should always be a positive number. Nevertheless, reports of experimental deposition in normal subjects sometimes do show negative depositions, e.g., an average of Ϫ5% in a group of 12 nonsmoking healthy women for a Vp of 250 ml (5). This contrasts with the average value found by Brand et al. (3) in a group of 79 asymptomatic nonsmoker subjects, i.e., 10% deposition for the same Vp, with no difference between female and male subjects. Although the much smaller depositions (5) could partly be accounted for by the 2.5-fold larger flows used in the study, these still do not explain negative deposition values.
A NUMBER OF EXPERIMENTAL STUDIES on normal subjects (3, 5) and in various groups of patients (1, 2, 4) use the analysis of expired aerosol concentration which is recovered after inhalation of a predefined aerosol bolus. The inspired bolus is a small aerosol volume that ranges between 20 and 300 ml (3, 5) . Lung behavior is then usually characterized in terms of aerosol bolus dispersion and/or deposition. Usually, deposition is determined for aerosol boluses delivered at various lung depths by varying the air volume after the aerosol bolus, while keeping preinspiratory lung volume and total inspired volume constant. Deposition is then plotted as a function of penetration volume (Vp), defined as the volumetric difference between the occurrence of inspired aerosol peak and the end of inspiration. For any inhaled bolus, some deposition is likely to occur; therefore, measured deposition should always be a positive number. Nevertheless, reports of experimental deposition in normal subjects sometimes do show negative depositions, e.g., an average of Ϫ5% in a group of 12 nonsmoking healthy women for a Vp of 250 ml (5) . This contrasts with the average value found by Brand et al. (3) in a group of 79 asymptomatic nonsmoker subjects, i.e., 10% deposition for the same Vp, with no difference between female and male subjects. Although the much smaller depositions (5) could partly be accounted for by the 2.5-fold larger flows used in the study, these still do not explain negative deposition values.
Existing reports of deposition data on normal subjects with the use of comparable aerosol bolus maneuvers and flows show substantial differences. For example, Brand et al. (3) and Anderson et al. (1, 2) report average depositions in healthy subjects of 30, 25, and 45%, respectively, at a Vp of 600 ml. There are only small methodological differences among these groups in terms of aerosol size (0.8 or 1 µm), end-inspiratory lung volume, inspired aerosol bolus volume (20-70 ml), the presence or absence of a dental compound to fill the mouth cavity, and the computation method employed. The large range of normal deposition values measured in these studies suggests another source of variability.
In this study, we show how the aerosol delivery system itself can affect deposition results to the extent that in a normal subject 1) deposition becomes negative at low Vp and 2) deposition is underestimated over a wider Vp range. We tested the hypothesis that deposition is crucially dependent on the shape of the inspired bolus through the way it is delivered and measured. First, inhaled bolus shape was investigated by using a 2-liter syringe to pull a 60-ml aerosol bolus through a photometer, with the aerosol delivery system in different configurations. We then used two configurations that gave the most widely different inspired bolus shapes to show that deposition differences of up to 25% can be obtained in the same normal subject, solely depending on the aerosol delivery system. Finally, we evaluated to what extent the deposition results obtained in the two configurations are affected by the computation method used. On the basis of our observa-
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tions, we suggest specific aspects of inspired aerosol bolus shape that should be checked in any existing aerosol bolus delivery system.
METHODS

Experimental Configuration
The experimental configuration is depicted in Fig. 1 . It comprises a bag-in-box system that connects to the subject's mouthpiece via a series of computer-driven, pneumatic, sliding valves (valves 1, 2, and 3; Hans-Rudolph, Kansas City, MO) and a nonrebreathing (NR) valve to separate inspiratory and expiratory pathways. A pneumotachograph fitted to the wall of the bag-in-box was used to monitor air flow occurring in the breathing assembly. Two devices (see Aerosol-Measurement Devices) could be used together or separately for particle monitoring during an aerosol experiment. The data acquisition and control for all experiments was done by using Labview (National Instruments, Austin, TX). All data acquisition was performed at 100 Hz by using a 16-bit analog-todigital card (AT-MIO-16X, National Instruments).
The system was designed for volume-controlled aerosol bolus inhalation in human subjects. A typical subject test sequence started with some tidal breaths, i.e., clean air inhalation from the box (via NR valve and valve 1) and exhalation to the expiratory bag (via valve 1 and NR valve). Simultaneously, the aerosol was generated into an open circuit through the aerosol tube between valves 3 and 2, with a volume of 60 ml between them. The actual bolus test was then started with clean air inhalation from functional residual capacity (FRC) until a predefined volume was reached, and valves 1, 2, and 3 were reversed, so that the aerosol volume between valves 2 and 3 is inhaled. This was followed by clean air beyond valve 3 from the box until the integrated pneumotachograph signal reached the preset inspired volume. The subject then exhaled to residual volume into the exhalation bag. In the human bolus tests, the preset inspired volume was 1 liter at all times, and the inspiratory pathway was not blocked at end inspiration.
To minimize inspiratory particle losses, valves and connecting tubes were designed such that the lumen of the aerosol pathway (valve 3 to photometer P1) was large and of constant diameter throughout (22 mm ID). The volume between valves 2 and 1 was 15 ml. The volume between valve 1 and photometer P1 was 25 ml, with the sampling tube for the particle counter P2 between them. The mouthpiece was directly connected to the photometer P1.
Aerosol-Measurement Devices
The laser photometer P1 (PARI photometer type 99 3000, Starnberg, Germany) measures aerosol concentration in-line. It uses a laser sheet covering ϳ75% of the main tube cross section. Particles that cross the laser sheet scatter light that is collected by a photomultiplier which produces an analog voltage (9) . In the absence of aerosol particles, the laser photometer produces a voltage representative of background noise due to stray light. This background noise is subtracted from the raw aerosol-concentration signal, with the remaining voltage being proportional to particle-number concentration in the case of a monodisperse aerosol (9).
The particle counter P2 is a customized version of the commercially available optical particle counter PCS-2000 (PALAS, Karlsruhe, Germany), which uses a white-light source to illuminate a measurement volume through which particles have to move singly. The particle counter P2 samples part of the respired gas stream via a 6-mm-ID sampling tube that can be fitted to sample (at 2 l/min) either from the center or from the edge of the main breathing tube. Inside the particle counter, the aerosol is diluted (10:1) before it passes through the optically defined measurement volumes to count particles up to number concentrations of 10 6 particles/cm 3 . The first factory-installed modification incorporated in our particle counter P2 was the addition of an extra measurement volume and an extra photomultiplier for the optimization of measurement in the concentration range below 20,000 particles/cm 3 . In the present study, aerosol concentration was in this low concentration range, as is usually the case for this type of experiment. The second factory-installed modification was the particle-counter software, which integrated signals from the low-and high-concentration range and ensured continuity between them.
System Configurations
Five separate configurations were tested. Unobstructed configuration. This corresponds to the configuration depicted in Fig. 1 , which provided a straight, smoothwalled path, with 22-mm ID, from valve 3 to the photometer P1.
Coarse-mesh configuration. In this case, a nylon mesh with 1-mm openings was fixed to a 22-mm OD ring which fitted in the connecting tube between valves 1 and 2, immediately adjacent to valve 2. As a consequence, the bolus, when inhaled, immediately passed through the mesh.
Fine-mesh configuration. This is similar to the coarse-mesh configuration, except that the openings in the mesh were 0.04 mm. The mesh originated from a model 3830 pneumotachograph (Hans-Rudolph).
Turbine configuration. A fixed turbine device, taken from a Microloop spirometer (Micro Medical, Kent, UK), was inserted in place of the mesh.
A 90°angle configuration. An elbow tube (ID ϭ 19 mm) was inserted between valves 1 and 2 so that the inhaled bolus was forced to negotiate a 90°bend before passing the photometer Fig. 1 . Schematic representation of aerosol bolus-delivery system in unobstructed configuration, which was used either with both photometer (P1) and particle-counter (P2) measurement or with only photometer P1 measurement. In the cases in which particle counter P2 was used, its sampling tube was positioned either in the center or on the edge of the breathing tube. Alternative system configurations used in this study consisted of introducing different degrees of disturbance to flow between valves 1 and 2 (see System Configurations for details). NR, nonrebreathing valve; EX, expiratory.
P1. In this configuration, there were no other disturbances in the flow path itself.
Experimental Protocol
The monodisperse aerosols which we used were prepared from a 10% solid aqueous suspension of latex particles with diameters of 0.50 Ϯ 0.01 (SD), 1.07 Ϯ 0.01, or 2.04 Ϯ 0.04 µm (Duke Scientific, Palo Alto, CA). After dilution in distilled deionized water (aqua ad iniectabilia; Braun, Melsungen, Germany) and nebulization (Acorn II; Marquest Medical Products, Englewood, CO), the latex particles were dried in a silica gel tunnel, the efficacy of which was tested at regular intervals by checking that the photometer signals did not rise above clean air levels when the nebulizer was filled with water only.
The study was conducted in two parts. Syringe tests. Syringe tests were performed by using a 2-liter syringe connected to the photometer, via a filter, to simulate a 2-liter inhalation with release of the aerosol after 1 liter had been inhaled. The operator pulling the syringe was aided, by a visual feedback of flow on the computer screen, to achieve a constant flow rate of 300 ml/s. A single sequence involved three syringe tests, in each of the five system configurations, for a total of 15 tests. One test sequence was performed for each particle size (0.5, 1, and 2 µm). For these syringe-test sequences, only the photometer P1 was used. After intermediate computation of the results, the 1-µm aerosol tests were repeated in the unobstructed and in the 90°a ngle configurations by using both the photometer P1 and the particle counter P2, with the particle-counter-sampling tube positioned either in the center or on the edge of the breathing tube.
Human tests. A normal subject performed two sequences of 15 aerosol bolus experiments: one sequence in the unobstructed configuration and one in the 90°angle configuration. Each of the subject test sequences consisted of aerosol boluses inhaled between FRC and FRC ϩ 1 liter and was targeted to cover Vp ranging between 150 and 650 ml, alternately performed in increasing or decreasing Vp order. At endinspiratory lung volume of 1 liter above FRC, the subject immediately exhaled to residual volume. The subject was aided by flow on the computer screen to target inspiratory and expiratory flows at ϳ300 ml/s. Because the inspiratory pathway was not blocked at 1 liter above FRC, the intended Vp could increase slightly because of further subject inhalation. After each test, it was checked that this 1-liter inspired volume overshoot never exceeded 50 ml, that the subject flows were within a 10% margin around 300 ml/s, and that endinspiratory breath hold was Ͻ1 s. For these experiments, we used the 1-µm-diameter aerosol, monitoring the experiments only with the photometer P1. The subject performed some extra tests in the unobstructed and 90°angle configuration, with a Vp targeted to ϳ400 ml, this time using both the photometer P1 and the particle counter P2, with the sampling tube positioned either on the edge or in the center of the breathing tube.
Before each test sequence, pneumotachograph-derived flows were calibrated with a 2-liter syringe, at a flow of ϳ300 ml/s, which was the same as the target flow for all syringe and subject aerosol experiments. In those cases in which the particle counter (with a sampling flow of ϳ2 l/min) was used in the setup, flow calibration involved an extra zero-flow adjustment, as described below. With the mouthpiece blocked (zero flow) and the particle counter P2 continuously sampling air via the NR valves and valve 1 from the bag-in-box (Fig. 1) , flow was offset by software to obtain a zero reading.
Data Analysis
Signals from the photometer P1 and the particle counter P2 were plotted against the respired volume of the syringe or subject. For each test, the baseline value of the raw photometer P1 signal was then determined in the volume range preceding the incoming aerosol bolus front. This baseline was subtracted from the raw photometer P1 signal. No baseline had to be subtracted from the particle counter P2 signal because this was directly proportional to number concentration. When traces from the photometer and the particle counter were to be compared, respective peak values of the inspired bolus were first normalized to 1.
In the case of the syringe tests, the photometer concentration traces were used to compute inhaled-bolus half-width (H in ) by measuring the volumetric width of the photometer signal at one-half peak height. We also determined three bolus volumes representing the volumes which contained 85, 90, and 95% of the total quantity of the bolus (Vol 85% , Vol 90% , and Vol 95% , respectively). For instance, Vol 85% was determined such that
where C is the aerosol concentration, V is volume, and Vol 0 is the volume corresponding to the onset of the incoming bolus front (i.e., first photometer concentration above background noise level). A large value of these bolus volumes compared with the half-width is indicative of a long tail on the bolus. Vol 90% is directly comparable to the measurement in McNamee and Boykin (7). In the case of subject aerosol tests, we computed dispersion (H) by using
where H in and H ex are the half-width of inspired and expired bolus, respectively. Deposition (De) was calculated by using
Deposition was computed using three different methods: 1) by integration over the entire inspired-and expired-volume range, 2) by integration over the volume range in which C was at least 5% of the peak expiratory aerosol concentration, and 3) by integration over the inspired-volume range in which C was at least 5% of the peak inspiratory aerosol concentration, and over the expired-volume range in which C was at least 5% of the peak expiratory aerosol concentration. The choice of 5% was based on previously reported values ranging from 1 to 15%, depending on the applied method (1) (2) (3) 5) , and the intentional use of the same percentage for methods 2 and 3.
Statistical Analysis
By using Statistica 5.1 (StatSoft, Tulsa, OK), one-and two-way analyses of variance were performed, with aerosol size, configuration, and Vp as categorical variables. Post hoc Bonferroni adjustment was used, with a significance level set at P ϭ 0.05. Figure 2 summarizes the half-width and bolus volume data computed from the syringe-inhaled aerosol boluses delivered with the setup in the five different configurations and with only the photometer P1 performing the measurement. The data are presented in order of increasing H in (Fig. 1A) and Vol 85% , Vol 90% , and Vol 95% (Fig. 2B) . Figure 2 shows values (means Ϯ SD) after we pooled, for each configuration, the data obtained with 0.5-, 1-, and 2-µm aerosols. This was done because, in each given configuration, no differences appeared between data corresponding to different aerosol size (one-way ANOVA, with particle size as the categorical variable). We also checked that no significant flow differences existed between tests performed in any two of the five configurations in Fig. 2 (one-way ANOVA, with configuration as the categorical variable). Mean flow averaged across configurations was 306 Ϯ 22 (SD) ml/s.
RESULTS
Syringe Results
We checked for H in , Vol 85% , Vol 90% , or Vol 95% differences among the different configurations in Fig. 2 . Essentially, H in was different between any two configurations, except between coarse mesh and fine mesh. In contrast, Vol 85% , Vol 90% , and Vol 95% differed only between unobstructed and coarse mesh, which in turn differed from the remaining three configurations. There was no difference in Vol 85% , Vol 90% , or Vol 95% among fine mesh, turbine, and 90°angle configurations. Note how, in the worst-case scenario presented here (unobstructed), 95% of the aerosol that was originally confined to a 60-ml tube became spread over 450 ml, with a corresponding half-width of only 42 ml. Except for the unobstructed configuration, all other configurations produced inhaled aerosol boluses with 85% of the aerosol contained in ϳ100 ml (Vol 85% in Fig. 2B ). In fine mesh, turbine, and 90°angle configurations, it took another 100 ml to contain an additional 10% of the aerosol (difference between Vol 85% and Vol 95% ). The bolus tail spread is evidenced by the large increment between Vol 95% and Vol 90% vs. that between Vol 90% and Vol 85% .
For the two most widely different configurations in terms of H in and Vol 85% , Vol 90% , and Vol 95% in Fig. 2 (i. e., the unobstructed and 90°angle configurations), both particle counter P2 and photometer P1 measurements are shown in Fig. 3 (dotted and solid lines, respectively) . Figure 3 shows the result of positioning the particle counter P2 sampling tube either in the center (A and C) or on the edge (B and D) of the breathing tube. The mismatch between photometer P1 and particle counter P2 traces in the unobstructed configuration (Fig. 3, A and B) contrasts with the match between corresponding signals in the 90°angle configuration (Fig. 3, C and  D) . In the unobstructed configuration, the degree of mismatch differs, depending on whether the particle counter is sampling from the center or from the edge of the breathing tube. In the 90°angle configuration, photometer P1 and particle-counter P2 traces coincide, regardless of whether the particle counter is sampling from the center or the edge of the breathing tube. Figure 4 shows the dispersion data (A) and deposition data (B) derived from the bolus measurements obtained from the subject in the unobstructed configuration (open bars) and the 90°angle configuration (solid bars). The data were grouped into five Vp values, i.e., Vp ϭ 200, 300, 400, 500, and 600 ml. Data for each Vp were obtained by averaging all data falling within Vp Ϯ 50 ml. A two-way ANOVA, using configuration and Vp as categorical variables, showed no dependence of flow on these variables. Mean flow averaged over all tests in 1, 2, and 3) . In particular, the values listed under deposition, method 1, in Table 1 are those corresponding to the data points in Fig. 4B . Finally, inhaled and exhaled aerosol behavior in the unobstructed and 90°angle configurations through the comparison of photometer P1 and particle counter P2 traces obtained on the subject for an aerosol bolus test with an intermediate Vp of ϳ400 ml can be summarized as follows. Aerosol boluses inhaled by the subject in the unobstructed configuration (Fig. 5) presented the same P1-to-P2 mismatch as the syringe bolus in the unobstructed configuration (Fig. 3A) . Aerosol boluses inhaled by the subject in the 90°angle configuration (not shown) reproduced the agreement between the photometer P1 and the particle counter P2 that was obtained with the syringe (Fig. 3, C and D) . However, in both configurations, there was a good agreement between expiratory P1 and P2 concentration traces regardless of whether the P2 sampling tube was fitted to the center (Fig. 5) or the edge of the breathing tube.
Subject Results
DISCUSSION
In this study, we illustrate how measurement errors of the inspired aerosol bolus can lead to severe experimental underestimation of aerosol bolus deposition. This type of experimental underestimation is present at all Vp values and is the greatest for low Vp (Fig. 4B) , an observation which holds for all three depositioncomputation methods used here (Table 1) . Although deposition measurement appears to be highly sensitive to the method of inhaled aerosol bolus delivery, this is not the case for aerosol bolus dispersion in terms of H, which was hardly affected by inhaled bolus shape (Fig.  4A) .
To provide an insight into the causes which contribute to the observed differences between the two most widely differing configurations, we compared simultaneous recordings of the syringe boluses with an in-line photometer P1 and on-line sampling particle counter P2 (Fig. 3) . Figure 3 , C and D, shows that, in the 90°a ngle configuration, the time course of the aerosol concentration measured by the photometer P1 matched the time course of the aerosol concentration measured by particle counter P2, regardless of the radial position of the P2-sampling tube in the main breathing tube. In contrast, in the unobstructed configuration (Fig. 3, A  and B) , the mismatch between the photometer P1 and the particle counter P2 suggests a parabolic flow profile of the incoming bolus. This is plausible, because we are dealing with Reynold's numbers of ϳ1,000 (flow, ϳ300 ml/s; tube diameter, 2.2 cm). Figure 3 clearly indicates that, under these flow conditions, the aerosol bolus pathway from reservoir to photometer should contain some degree of disturbance to mix the aerosol with the surrounding air so that the aerosol front becomes blunt enough and the photometer P1 measurement may indeed be considered representative of aerosol concentration over the entire tube cross section.
Although the comparisons of photometer P1 and particle counter P2 traces in Fig. 3 could actually provide an explanation for the inadequacy of the photometer measurement, depending on the configuration of the aerosol delivery system, detailed analysis of the photometer traces themselves also reveals distinct differences. For instance, the 90°angle configuration provided a combination of relatively high H in (Fig. 2A) and relatively low volumetric confinement of the aerosol in terms of Vol 85% , Vol 90% , and Vol 95% (Fig. 2B ) in contrast to the unobstructed configuration. These results suggested that the photometer may underestimate actual inhaled aerosol concentration, depending on the configuration of the aerosol delivery system. To further test this hypothesis, we used a relative bolus measurement by having a normal subject perform bolus inhalations. This provides a measure of the magnitude of the experimental error on bolus parameters with clinical relevance.
The tests in a normal subject revealed that, with inhaled boluses delivered in both unobstructed and 90°a ngle configuration, the photometer and particlecounter traces were matched during subject exhalation, regardless of whether the particle-counter-sampling tube was in the center or on the edge of the breathing tube. This is shown by Fig. 5 , representing the worst case, in which the inhaled bolus reproduced the mismatch between the photometer and the particle counter that was previously seen in the syringe tests. In contrast, the exhaled bolus showed no differences between the photometer and the particle counter traces. This suggests that, during exhalation, the photometer Values are means Ϯ SD for deposition. V p , penetration volume, with subject maneuver 1-liter inhalation from functional residual capacity and expiration to residual volume. method 1, using Eq. 3 by integration over entire inspired and expired volume range; method 2, using Eq. 3 by integration over volume range in which concentration is Ն5% of peak expiratory aerosol concentration; method 3, using Eq. 3 by integration over inspired volume range in which concentration is Ն5% of peak inspiratory aerosol concentration, and over expired volume range in which concentration is Ն5% of peak expiratory aerosol concentration. ⌬Deposition, difference in deposition between 90°angle and unobstructed modes. measurement is representative of the entire tube cross section, probably because the glottis and the mouth cavity provide sufficient disturbance to blunt the aerosol-flow profile. If we accept that an inadequately delivered bolus primarily affects the recorded inhaled bolus shape and not the exhaled bolus, it follows that overall bolus dispersion will not be affected. Because the bolus H ex is usually at least triple that of the bolus H in over the Vp range under study, the effect of an underestimation of the bolus H in of a few milliliters will be marginal and will be largely overridden by the variability of dispersion measurement itself. Figure 4A confirms this experimentally.
The subject experiments shown in Fig. 5 also indicated that, when the aerosol-flow profile is insufficiently blunted as the aerosol bolus enters the photometer, this leads to an underestimated inhaled-aerosol quantity, whereas exhaled-aerosol quantity measurement is unaffected. This implies that deposition (De in Eq. 3) will be underestimated. Also, a given absolute underestimation of the inspired bolus quantity is expected to provide different degrees of deposition underestimation, depending on actual deposition in the lungs and, therefore, Vp level (with the greater underestimation occurring at low values of Vp). Figure 4B indeed shows that experimental deposition values are generally smaller in the unobstructed than in the 90°angle configuration and that the absolute deposition difference between both configurations is indeed greater for Vp ϭ 200 ml than for Vp ϭ 600 ml. Table 1 , bottom, shows that the pattern of larger deposition difference between configurations for smaller Vp holds for all three computation methods used. It would be expected that the computation methods which discard part of the bolus tail, such as method 2 or 3, would produce quite different deposition values, because the system configuration has a marked effect on the shape of the inspired-bolus signal in terms of volumetric confinement of the bolus tail (Fig. 2B) . Table  1 , top, clearly shows that the differences in deposition values, in particular between methods 1 and 3, are substantial in the unobstructed configuration but virtually disappear in the 90°angle configuration. From this result, we may conclude that, provided the aerosol setup delivers proper quality of the inhaled bolus, the deposition-computation methods presented here will produce comparable results.
The comparison of aerosol bolus data obtained in different laboratories by using slightly different experimental and computational methodologies is difficult and should be handled with caution when the reported normal values are used as a reference (3) . The genesis of errors in deposition, in which the underestimation sometimes becomes apparent through the negative values for small Vp values, may actually be quite subtle. In previous papers, inhaled-aerosol bolus characteristics are usually restricted to the mention of bolus half-width, with a general tendency to decrease bolus H in as much as technically possible [e.g., 20 ml in Brand et al. (3) ], to target the aerosol bolus to narrower lung volumes at a given lung depth. Although the inhaled bolus may indeed be conveniently quantified by its half-width, Fig. 2 clearly shows how a small H in can nevertheless be associated with a large volumetric spread of the total amount of aerosol (Vol 85% , Vol 90% , and Vol 95% ). Even in the best-case scenario, the bolus may still be quite widely spread, as can be seen from the Vol 90% for the 90°angle configuration, i.e., 120 ml for a 60-ml aerosol reservoir, a result which is similar to that in the study by McNamee and Boykin (7), in which a Vol 90% of 61 ml was obtained for an original aerosol volume of 35 ml.
In a previous work that concerned the use of lightscattering photometry in aerosol medicine, Gebhart et al. (6) stated that ''before an aerosol enters the photometer, it has to be thoroughly mixed so that the aerosol concentration passing through the sensitive area of the photometer is representative for the whole cross section of the aerosol channel.'' To our knowledge, the only precise indication of how to achieve this condition is in a paper by Smaldone et al. (8) , in which a figure legend refers to right angles in the setup to ''promote mixing in tubing and minimize streaming in the aerosol measurement device.'' In most other studies, the schematic representation of the aerosol setup suggests that this right-angle strategy is not the only one that could be used. It is, therefore, not unreasonable to think that different kinds of obstructions used in different aerosol laboratories may lead to different qualities of the Fig. 5 . Example of aerosol bolus inhalation and exhalation in a subject, plotted as a function of cumulatively inhaled and exhaled volume, with both photometer P1 and particle-counter P2 measurements. This test corresponds to a 1-liter inhalation from functional residual capacity, with Vp of 400 ml, followed by an exhalation down to residual volume, which in this case was 1.5 liters below functional residual capacity. The question that remains is how to assess whether inhaled aerosol boluses are adequately delivered and measured. We recommend first testing the sensitivity of the inhaled aerosol bolus shape to the insertion of any kind of disturbance or, if possible, a 90°angle between aerosol reservoir and photometer. Syringe tests, such as the ones described here, should be performed by using flows corresponding to those that would be used in experiments on human subjects or in patients. The resulting aerosol boluses, as measured by the photometer, can be evaluated most readily by their H in . When the entire contents of the aerosol bolus reservoir are delivered, as was the case here, one would like H in to be as close as possible to the aerosol-reservoir volume. In some cases, the aerosol is not originally contained in a well-defined volume but is sampled from a larger reservoir by a system of rapidly switching valves. In this case, one can simply observe whether H in increases at all when flow is disturbed in one way or another. In addition to H in measurement, the quality control of inhaled bolus could also benefit from the evaluation of its volumetric confinement in terms of parameters such as Vol 85% and Vol 95% . In particular, the latter (parameters) provide a means of characterizing the aerosol bolus tail, which remains one of the limitations of bolus delivery experiments in general.
EXPERIMENTAL ERROR IN AEROSOL BOLUS TESTS
